• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSL

ONCOSIL MEDICAL LTD - Announcements

1.80% ! $1.09
Market Cap $20.51M  !

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

Announcements



OSL EGM Notice of Meeting & Proxy Form13/04/18 download Created with Sketch. 915.1KB
OSL Oncosil Medical Share Purchase Plan Closing Date Reminder11/04/18 download Created with Sketch. 494.06KB
OSL Oncosil Medical presents at Proactive Investors CEO Sessions09/04/18 download Created with Sketch. 2.18MB
OSL Clinical Programme UpdatePRICE SENSITIVE04/04/18 download Created with Sketch. 737.83KB
OSL Change in substantial holding03/04/18 download Created with Sketch. 247.28KB
OSL CEO Interview - Clinical data update and outlook video03/04/18 download Created with Sketch. 489.91KB
OSL Ceasing to be a substantial holder for OSL28/03/18 download Created with Sketch. 77.32KB
OSL Oncosil Medical Share Purchase PlanPRICE SENSITIVE28/03/18 download Created with Sketch. 1.27MB
OSL Cleansing Statement & Appendix 3B28/03/18 download Created with Sketch. 1.17MB
OSL Successful Completion of Capital RaisingPRICE SENSITIVE22/03/18 download Created with Sketch. 529.32KB
OSL Presentation-Surgical Resection Outcomes and Capital RaisingPRICE SENSITIVE21/03/18 download Created with Sketch. 3.25MB
OSL Surgical Resection Outcomes and Capital RaisingPRICE SENSITIVE21/03/18 download Created with Sketch. 539.5KB
OSL Trading HaltPRICE SENSITIVE21/03/18 download Created with Sketch. 658.38KB
OSL OncoSil Company Update Presentation08/03/18 download Created with Sketch. 2.39MB
OSL Appendix 3B02/03/18 download Created with Sketch. 716.89KB
OSL Positive Early Study Results ContinuePRICE SENSITIVE28/02/18 download Created with Sketch. 844.65KB
OSL Appendix 4D & Half Yearly Report and AccountsPRICE SENSITIVE21/02/18 download Created with Sketch. 1.03MB
OSL Change in substantial holding08/02/18 download Created with Sketch. 169.18KB
OSL First Subject Recruited in the United StatesPRICE SENSITIVE08/02/18 download Created with Sketch. 650.6KB
OSL Response to ASX Appendix 4C QueryPRICE SENSITIVE08/02/18 download Created with Sketch. 895.01KB
OSL Change of Director's Interest Notice - Appendix 3Y30/01/18 download Created with Sketch. 256.99KB
OSL Change of Director's Interest Notice - Appendix 3Y30/01/18 download Created with Sketch. 255.74KB
OSL Final share buy-back notice - Appendix 3F30/01/18 download Created with Sketch. 421.26KB
OSL Appendix 4C & Quarterly UpdatePRICE SENSITIVE29/01/18 download Created with Sketch. 1.01MB
OSL Additional Receipt of $0.6m R&D Tax Incentive RefundPRICE SENSITIVE16/01/18 download Created with Sketch. 524.73KB
OSL Appendix 3C - Employee Loan Share Buy BackPRICE SENSITIVE11/01/18 download Created with Sketch. 188.19KB
OSL 20th Patient implanted with OncoSil device10/01/18 download Created with Sketch. 675.86KB
OSL Progress Update on Global Pancreatic Cancer Clinical StudyPRICE SENSITIVE21/12/17 download Created with Sketch. 675.07KB
OSL Loan Share Vesting Conditions Met23/11/17 download Created with Sketch. 111.02KB
OSL Appendix 4C & Quarterly UpdatePRICE SENSITIVE31/10/17 download Created with Sketch. 341.8KB
OSL Change in substantial holding26/10/17 download Created with Sketch. 104.87KB
OSL Results of Annual General Meeting 201725/10/17 download Created with Sketch. 136.4KB
OSL Australia Biotech Invest 2017 Presentation24/10/17 download Created with Sketch. 1.35MB
OSL Positive Early Study Results Presented at EANM CongressPRICE SENSITIVE23/10/17 download Created with Sketch. 754.74KB
OSL Progress Update on Global Pancreatic Cancer Clinical StudyPRICE SENSITIVE16/10/17 download Created with Sketch. 134.68KB
OSL R&D RefundPRICE SENSITIVE25/09/17 download Created with Sketch. 136.51KB
OSL Progress update on Global Pancreatic Cancer Clinical StudyPRICE SENSITIVE22/09/17 download Created with Sketch. 149.74KB
OSL 2017 Notice of Meeting and Proxy Form21/09/17 download Created with Sketch. 218.58KB
OSL 2017 Oncosil Annual Report21/09/17 download Created with Sketch. 1.81MB
OSL 2017 Appendix 4G and Corporate Governance Statement21/09/17 download Created with Sketch. 290.57KB
OSL Appendix 4E - Preliminary Final Report 30 June 2017PRICE SENSITIVE24/08/17 download Created with Sketch. 947.07KB
OSL First UK subject recruitedPRICE SENSITIVE22/08/17 download Created with Sketch. 142.56KB
OSL CE Mark & Quarterly Activity UpdatePRICE SENSITIVE31/07/17 download Created with Sketch. 426.3KB
OSL Resignation of Company Secretary25/07/17 download Created with Sketch. 100.03KB
OSL Change in substantial shareholder17/05/17 download Created with Sketch. 56.42KB
OSL Cleansing Notice & Appendix 3B12/05/17 download Created with Sketch. 234.32KB
OSL Second subject recruited at Monash Health MelbournePRICE SENSITIVE11/05/17 download Created with Sketch. 114.65KB
OSL Dr Roger Aston, Non-Executive Director04/05/17 download Created with Sketch. 108.52KB
OSL Appointment of Dr Chris Roberts AO as Chairman03/05/17 download Created with Sketch. 130.88KB
OSL Appendix 4C and Quarterly updatePRICE SENSITIVE27/04/17 download Created with Sketch. 270.86KB
OSL First OncoSil Device Implantation procedure completedPRICE SENSITIVE26/04/17 download Created with Sketch. 107.68KB
OSL Specialised Therapeutics Australia supporting OncoSil studyPRICE SENSITIVE20/04/17 download Created with Sketch. 147.08KB
OSL US IRB Approval, MD Anderson Cancer CentrePRICE SENSITIVE19/04/17 download Created with Sketch. 130.17KB
OSL Loan Share Vesting Conditions Met10/04/17 download Created with Sketch. 115.58KB
OSL Notice of change of substantial holder10/04/17 download Created with Sketch. 141.91KB
OSL UK Central Ethics ApprovalPRICE SENSITIVE04/04/17 download Created with Sketch. 148.87KB
OSL First subject recruitedPRICE SENSITIVE28/03/17 download Created with Sketch. 148.1KB
OSL Appendix 3X - Initial Directors Interest Notice28/02/17 download Created with Sketch. 63.87KB
OSL Dr Martin Cross appointed Non-Executive Director28/02/17 download Created with Sketch. 152.53KB
OSL Appendix 4D & Half Year AccountsPRICE SENSITIVE23/02/17 download Created with Sketch. 1.38MB
OSL MHRA Approval to commence study in UKPRICE SENSITIVE13/02/17 download Created with Sketch. 134.81KB
OSL CE Mark UpdatePRICE SENSITIVE08/02/17 download Created with Sketch. 148.59KB
OSL Ethics Approval for OncoPac Clinical StudyPRICE SENSITIVE02/02/17 download Created with Sketch. 141.38KB
OSL Appendix 4C - Quarterly Cash FlowPRICE SENSITIVE27/01/17 download Created with Sketch. 237.57KB
OSL Amended Escrow Date20/01/17 download Created with Sketch. 116.56KB
OSL Loan Share Vesting Conditions Met20/01/17 download Created with Sketch. 116.11KB
OSL Pancreatic cancer clinical study updatePRICE SENSITIVE28/11/16 download Created with Sketch. 150.88KB
OSL OncoSil Presents at Wilsons Rapid Insights Conference10/11/16 download Created with Sketch. 1.55MB
OSL Appendix 4C - Quarterly Cash Flow-OSL.AX PRICE SENSITIVE27/10/16 download Created with Sketch. 236.8KB
OSL Final Director's Interest Notice - Martin Rogers-OSL.AX 19/10/16 download Created with Sketch. 285.54KB
OSL 2016 Results od Annual General Meeting-OSL.AX 18/10/16 download Created with Sketch. 137.72KB
OSL CEO Presentation - AGM 18th October 2016-OSL.AX 18/10/16 download Created with Sketch. 1.18MB
OSL Receipt of $2.3m R & D Tax Incentive Refund-OSL.AX PRICE SENSITIVE26/09/16 download Created with Sketch. 130.38KB
OSL 2016 Amended - Appendix 4G-OSL.AX 13/09/16 download Created with Sketch. 776.56KB
OSL 2016 AGM Notice of Meeting - Proxy Form-OSL.AX 12/09/16 download Created with Sketch. 384.36KB
OSL 2016 Corporate Governance - Appendix 4G-OSL.AX 12/09/16 download Created with Sketch. 753.7KB
OSL 2016 Annual Report-OSL.AX 12/09/16 download Created with Sketch. 1.85MB
OSL Appendix 4E - Preliminary final report 30 June 2016-OSL.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 666.71KB
OSL Investor Presentation - Aug 2016-OSL.AX 22/08/16 download Created with Sketch. 1.78MB
OSL Hot Calibration Run of the OncoSil Device-OSL.AX PRICE SENSITIVE18/08/16 download Created with Sketch. 128.24KB
OSL Appendix 3B-OSL.AX 12/08/16 download Created with Sketch. 151.75KB
OSL FDA IDE Approval-OSL.AX PRICE SENSITIVE02/08/16 download Created with Sketch. 642.21KB
OSL Appendix 4C - Quarterly Cash Flow-OSL.AX PRICE SENSITIVE27/07/16 download Created with Sketch. 867.24KB
OSL 48th European Pancreatic Club meeting-OSL.AX 06/07/16 download Created with Sketch. 129.65KB
OSL Regulatory Update June 2016-OSL.AX PRICE SENSITIVE30/06/16 download Created with Sketch. 139.36KB
OSL Appendix 3B & Cleansing-OSL.AX 30/06/16 download Created with Sketch. 236.83KB
OSL Appoints Global Sales and Marketing Director-OSL.AX 18/05/16 download Created with Sketch. 127.44KB
OSL Cleansing Notice & Appendix 3B-OSL.AX 13/05/16 download Created with Sketch. 891.62KB
OSL Appendix 3B-OSL.AX 10/05/16 download Created with Sketch. 558.83KB
OSL Results of Extraordinary General Meeting-OSL.AX 09/05/16 download Created with Sketch. 353.77KB
OSL OncoSil Medical Presents at Asia BiotechInvest-OSL.AX 04/05/16 download Created with Sketch. 2MB
OSL Appendix 4C - Quarterly Cashflow-OSL.AX PRICE SENSITIVE28/04/16 download Created with Sketch. 214.82KB
OSL OncoSil Medical Change of Address-OSL.AX 19/04/16 download Created with Sketch. 100.02KB
OSL Cleansing Notice and Appendix 3B-OSL.AX 15/04/16 download Created with Sketch. 249.46KB
OSL OncoSil EGM Notice of Meeting-OSL.AX 08/04/16 download Created with Sketch. 166.16KB
OSL OncoSil Medical releases latest Investor Presentation23/03/16 download Created with Sketch. 1.02MB
OSL Withdrawal of Extraordinary General Meeting22/03/16 download Created with Sketch. 394.95KB
OSL OncoSil Market Update March 101/03/16 download Created with Sketch. 97.63KB
OSL Notice of Extraordinary General Meeting/Proxy Form25/02/16 download Created with Sketch. 178KB
OSL Appendix 4D & Half Year AccountsPRICE SENSITIVE15/02/16 download Created with Sketch. 392.97KB
OSL EGM Notice of Meeting & Proxy Form
13/04/18 download Created with Sketch. 915.1KB
OSL Oncosil Medical Share Purchase Plan Closing Date Reminder
11/04/18 download Created with Sketch. 494.06KB
OSL Oncosil Medical presents at Proactive Investors CEO Sessions
09/04/18 download Created with Sketch. 2.18MB
OSL Clinical Programme Update
04/04/18PRICE SENSITIVE download Created with Sketch. 737.83KB
OSL Change in substantial holding
03/04/18 download Created with Sketch. 247.28KB
OSL CEO Interview - Clinical data update and outlook video
03/04/18 download Created with Sketch. 489.91KB
OSL Ceasing to be a substantial holder for OSL
28/03/18 download Created with Sketch. 77.32KB
OSL Oncosil Medical Share Purchase Plan
28/03/18PRICE SENSITIVE download Created with Sketch. 1.27MB
OSL Cleansing Statement & Appendix 3B
28/03/18 download Created with Sketch. 1.17MB
OSL Successful Completion of Capital Raising
22/03/18PRICE SENSITIVE download Created with Sketch. 529.32KB
OSL Presentation-Surgical Resection Outcomes and Capital Raising
21/03/18PRICE SENSITIVE download Created with Sketch. 3.25MB
OSL Surgical Resection Outcomes and Capital Raising
21/03/18PRICE SENSITIVE download Created with Sketch. 539.5KB
OSL Trading Halt
21/03/18PRICE SENSITIVE download Created with Sketch. 658.38KB
OSL OncoSil Company Update Presentation
08/03/18 download Created with Sketch. 2.39MB
OSL Appendix 3B
02/03/18 download Created with Sketch. 716.89KB
OSL Positive Early Study Results Continue
28/02/18PRICE SENSITIVE download Created with Sketch. 844.65KB
OSL Appendix 4D & Half Yearly Report and Accounts
21/02/18PRICE SENSITIVE download Created with Sketch. 1.03MB
OSL Change in substantial holding
08/02/18 download Created with Sketch. 169.18KB
OSL First Subject Recruited in the United States
08/02/18PRICE SENSITIVE download Created with Sketch. 650.6KB
OSL Response to ASX Appendix 4C Query
08/02/18PRICE SENSITIVE download Created with Sketch. 895.01KB
OSL Change of Director's Interest Notice - Appendix 3Y
30/01/18 download Created with Sketch. 256.99KB
OSL Change of Director's Interest Notice - Appendix 3Y
30/01/18 download Created with Sketch. 255.74KB
OSL Final share buy-back notice - Appendix 3F
30/01/18 download Created with Sketch. 421.26KB
OSL Appendix 4C & Quarterly Update
29/01/18PRICE SENSITIVE download Created with Sketch. 1.01MB
OSL Additional Receipt of $0.6m R&D Tax Incentive Refund
16/01/18PRICE SENSITIVE download Created with Sketch. 524.73KB
OSL Appendix 3C - Employee Loan Share Buy Back
11/01/18PRICE SENSITIVE download Created with Sketch. 188.19KB
OSL 20th Patient implanted with OncoSil device
10/01/18 download Created with Sketch. 675.86KB
OSL Progress Update on Global Pancreatic Cancer Clinical Study
21/12/17PRICE SENSITIVE download Created with Sketch. 675.07KB
OSL Loan Share Vesting Conditions Met
23/11/17 download Created with Sketch. 111.02KB
OSL Appendix 4C & Quarterly Update
31/10/17PRICE SENSITIVE download Created with Sketch. 341.8KB
OSL Change in substantial holding
26/10/17 download Created with Sketch. 104.87KB
OSL Results of Annual General Meeting 2017
25/10/17 download Created with Sketch. 136.4KB
OSL Australia Biotech Invest 2017 Presentation
24/10/17 download Created with Sketch. 1.35MB
OSL Positive Early Study Results Presented at EANM Congress
23/10/17PRICE SENSITIVE download Created with Sketch. 754.74KB
OSL Progress Update on Global Pancreatic Cancer Clinical Study
16/10/17PRICE SENSITIVE download Created with Sketch. 134.68KB
OSL R&D Refund
25/09/17PRICE SENSITIVE download Created with Sketch. 136.51KB
OSL Progress update on Global Pancreatic Cancer Clinical Study
22/09/17PRICE SENSITIVE download Created with Sketch. 149.74KB
OSL 2017 Notice of Meeting and Proxy Form
21/09/17 download Created with Sketch. 218.58KB
OSL 2017 Oncosil Annual Report
21/09/17 download Created with Sketch. 1.81MB
OSL 2017 Appendix 4G and Corporate Governance Statement
21/09/17 download Created with Sketch. 290.57KB
OSL Appendix 4E - Preliminary Final Report 30 June 2017
24/08/17PRICE SENSITIVE download Created with Sketch. 947.07KB
OSL First UK subject recruited
22/08/17PRICE SENSITIVE download Created with Sketch. 142.56KB
OSL CE Mark & Quarterly Activity Update
31/07/17PRICE SENSITIVE download Created with Sketch. 426.3KB
OSL Resignation of Company Secretary
25/07/17 download Created with Sketch. 100.03KB
OSL Change in substantial shareholder
17/05/17 download Created with Sketch. 56.42KB
OSL Cleansing Notice & Appendix 3B
12/05/17 download Created with Sketch. 234.32KB
OSL Second subject recruited at Monash Health Melbourne
11/05/17PRICE SENSITIVE download Created with Sketch. 114.65KB
OSL Dr Roger Aston, Non-Executive Director
04/05/17 download Created with Sketch. 108.52KB
OSL Appointment of Dr Chris Roberts AO as Chairman
03/05/17 download Created with Sketch. 130.88KB
OSL Appendix 4C and Quarterly update
27/04/17PRICE SENSITIVE download Created with Sketch. 270.86KB
OSL First OncoSil Device Implantation procedure completed
26/04/17PRICE SENSITIVE download Created with Sketch. 107.68KB
OSL Specialised Therapeutics Australia supporting OncoSil study
20/04/17PRICE SENSITIVE download Created with Sketch. 147.08KB
OSL US IRB Approval, MD Anderson Cancer Centre
19/04/17PRICE SENSITIVE download Created with Sketch. 130.17KB
OSL Loan Share Vesting Conditions Met
10/04/17 download Created with Sketch. 115.58KB
OSL Notice of change of substantial holder
10/04/17 download Created with Sketch. 141.91KB
OSL UK Central Ethics Approval
04/04/17PRICE SENSITIVE download Created with Sketch. 148.87KB
OSL First subject recruited
28/03/17PRICE SENSITIVE download Created with Sketch. 148.1KB
OSL Appendix 3X - Initial Directors Interest Notice
28/02/17 download Created with Sketch. 63.87KB
OSL Dr Martin Cross appointed Non-Executive Director
28/02/17 download Created with Sketch. 152.53KB
OSL Appendix 4D & Half Year Accounts
23/02/17PRICE SENSITIVE download Created with Sketch. 1.38MB
OSL MHRA Approval to commence study in UK
13/02/17PRICE SENSITIVE download Created with Sketch. 134.81KB
OSL CE Mark Update
08/02/17PRICE SENSITIVE download Created with Sketch. 148.59KB
OSL Ethics Approval for OncoPac Clinical Study
02/02/17PRICE SENSITIVE download Created with Sketch. 141.38KB
OSL Appendix 4C - Quarterly Cash Flow
27/01/17PRICE SENSITIVE download Created with Sketch. 237.57KB
OSL Amended Escrow Date
20/01/17 download Created with Sketch. 116.56KB
OSL Loan Share Vesting Conditions Met
20/01/17 download Created with Sketch. 116.11KB
OSL Pancreatic cancer clinical study update
28/11/16PRICE SENSITIVE download Created with Sketch. 150.88KB
OSL OncoSil Presents at Wilsons Rapid Insights Conference
10/11/16 download Created with Sketch. 1.55MB
OSL Appendix 4C - Quarterly Cash Flow-OSL.AX
27/10/16PRICE SENSITIVE download Created with Sketch. 236.8KB
OSL Final Director's Interest Notice - Martin Rogers-OSL.AX
19/10/16 download Created with Sketch. 285.54KB
OSL 2016 Results od Annual General Meeting-OSL.AX
18/10/16 download Created with Sketch. 137.72KB
OSL CEO Presentation - AGM 18th October 2016-OSL.AX
18/10/16 download Created with Sketch. 1.18MB
OSL Receipt of $2.3m R & D Tax Incentive Refund-OSL.AX
26/09/16PRICE SENSITIVE download Created with Sketch. 130.38KB
OSL 2016 Amended - Appendix 4G-OSL.AX
13/09/16 download Created with Sketch. 776.56KB
OSL 2016 AGM Notice of Meeting - Proxy Form-OSL.AX
12/09/16 download Created with Sketch. 384.36KB
OSL 2016 Corporate Governance - Appendix 4G-OSL.AX
12/09/16 download Created with Sketch. 753.7KB
OSL 2016 Annual Report-OSL.AX
12/09/16 download Created with Sketch. 1.85MB
OSL Appendix 4E - Preliminary final report 30 June 2016-OSL.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 666.71KB
OSL Investor Presentation - Aug 2016-OSL.AX
22/08/16 download Created with Sketch. 1.78MB
OSL Hot Calibration Run of the OncoSil Device-OSL.AX
18/08/16PRICE SENSITIVE download Created with Sketch. 128.24KB
OSL Appendix 3B-OSL.AX
12/08/16 download Created with Sketch. 151.75KB
OSL FDA IDE Approval-OSL.AX
02/08/16PRICE SENSITIVE download Created with Sketch. 642.21KB
OSL Appendix 4C - Quarterly Cash Flow-OSL.AX
27/07/16PRICE SENSITIVE download Created with Sketch. 867.24KB
OSL 48th European Pancreatic Club meeting-OSL.AX
06/07/16 download Created with Sketch. 129.65KB
OSL Regulatory Update June 2016-OSL.AX
30/06/16PRICE SENSITIVE download Created with Sketch. 139.36KB
OSL Appendix 3B & Cleansing-OSL.AX
30/06/16 download Created with Sketch. 236.83KB
OSL Appoints Global Sales and Marketing Director-OSL.AX
18/05/16 download Created with Sketch. 127.44KB
OSL Cleansing Notice & Appendix 3B-OSL.AX
13/05/16 download Created with Sketch. 891.62KB
OSL Appendix 3B-OSL.AX
10/05/16 download Created with Sketch. 558.83KB
OSL Results of Extraordinary General Meeting-OSL.AX
09/05/16 download Created with Sketch. 353.77KB
OSL OncoSil Medical Presents at Asia BiotechInvest-OSL.AX
04/05/16 download Created with Sketch. 2MB
OSL Appendix 4C - Quarterly Cashflow-OSL.AX
28/04/16PRICE SENSITIVE download Created with Sketch. 214.82KB
OSL OncoSil Medical Change of Address-OSL.AX
19/04/16 download Created with Sketch. 100.02KB
OSL Cleansing Notice and Appendix 3B-OSL.AX
15/04/16 download Created with Sketch. 249.46KB
OSL OncoSil EGM Notice of Meeting-OSL.AX
08/04/16 download Created with Sketch. 166.16KB
OSL OncoSil Medical releases latest Investor Presentation
23/03/16 download Created with Sketch. 1.02MB
OSL Withdrawal of Extraordinary General Meeting
22/03/16 download Created with Sketch. 394.95KB
OSL OncoSil Market Update March 1
01/03/16 download Created with Sketch. 97.63KB
OSL Notice of Extraordinary General Meeting/Proxy Form
25/02/16 download Created with Sketch. 178KB
OSL Appendix 4D & Half Year Accounts
15/02/16PRICE SENSITIVE download Created with Sketch. 392.97KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.09
Change
-0.020(1.80%)
Mkt cap ! $20.51M
Open High Low Value Volume
$1.11 $1.12 $1.08 $19.98K 18.08K

Buyers (Bids)

No. Vol. Price($)
3 3196 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 3598 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.